Advertisement
Screener

PFIZER INC (PFE) Net Income (Loss) Attributable to Noncontrolling Interest

PFIZER INC Net Income (Loss) Attributable to Noncontrolling Interest

PFIZER INC (PFE) reported Net Income (Loss) Attributable to Noncontrolling Interest of $10.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-04

  • PFIZER INC net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-28 was $10.00M, a 44.44% decline year-over-year.
  • PFIZER INC net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-29 was $8.00M, a 33.33% increase year-over-year.
  • PFIZER INC net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $8.00M, a 0.00% change year-over-year.
  • PFIZER INC net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-28 was $9.00M, a 12.50% increase year-over-year.
  • PFIZER INC net income (loss) attributable to noncontrolling interest for fiscal 2025 was $41.00M, a 32.26% increase from fiscal 2024.
  • PFIZER INC net income (loss) attributable to noncontrolling interest for fiscal 2024 was $31.00M, a 20.51% decline from fiscal 2023.
  • PFIZER INC net income (loss) attributable to noncontrolling interest for fiscal 2023 was $39.00M, a 11.43% increase from fiscal 2022.
  • PFIZER INC net income (loss) attributable to noncontrolling interest for fiscal 2022 was $35.00M, a 22.22% decline from fiscal 2021.
Period endNet Income (Loss) Attributable to Noncontrolling Interest 3 monthNet Income (Loss) Attributable to Noncontrolling Interest 6 monthNet Income (Loss) Attributable to Noncontrolling Interest 9 monthNet Income (Loss) Attributable to Noncontrolling Interest 12 monthNet Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed
2026-06-28$10.00M
10-Q · filed 2026-08-04
$19.00M
10-Q · filed 2026-08-04
$26.00M
derived: sum of 3 quarters · filed 2026-08-04
$35.00M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-29$8.00M
10-Q · filed 2026-05-05
$16.00M
derived: sum of 2 quarters · filed 2026-05-05
$25.00M
derived: sum of 3 quarters · filed 2026-05-05
$43.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$8.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$17.00M
derived: sum of 2 quarters · filed 2026-02-26
$35.00M
derived: sum of 3 quarters · filed 2026-08-04
$41.00M
10-K · filed 2026-02-26
2025-09-28$9.00M
10-Q · filed 2025-11-04
$27.00M
derived: sum of 2 quarters · filed 2026-08-04
$33.00M
10-Q · filed 2025-11-04
$41.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-29$18.00M
10-Q · filed 2026-08-04
$24.00M
10-Q · filed 2026-08-04
$32.00M
derived: sum of 3 quarters · filed 2026-08-04
$40.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-30$6.00M
10-Q · filed 2026-05-05
$14.00M
derived: sum of 2 quarters · filed 2026-05-05
$22.00M
derived: sum of 3 quarters · filed 2026-05-05
$29.00M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$8.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$16.00M
derived: sum of 2 quarters · filed 2026-02-26
$23.00M
derived: sum of 3 quarters · filed 2026-02-26
$31.00M
10-K · filed 2026-02-26
2024-09-29$8.00M
10-Q · filed 2025-11-04
$15.00M
derived: sum of 2 quarters · filed 2025-11-04
$23.00M
10-Q · filed 2025-11-04
$32.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$7.00M
10-Q · filed 2025-08-05
$15.00M
10-Q · filed 2025-08-05
$24.00M
derived: sum of 3 quarters · filed 2026-02-26
$30.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$8.00M
10-Q · filed 2025-05-05
$17.00M
derived: sum of 2 quarters · filed 2026-02-26
$23.00M
derived: sum of 3 quarters · filed 2026-02-26
$34.00M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$9.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$15.00M
derived: sum of 2 quarters · filed 2026-02-26
$26.00M
derived: sum of 3 quarters · filed 2026-02-26
$39.00M
10-K · filed 2026-02-26
2023-10-01$6.00M
10-Q · filed 2024-11-04
$17.00M
derived: sum of 2 quarters · filed 2024-11-04
$30.00M
10-Q · filed 2024-11-04
$38.00M
derived: sum of 4 quarters · filed 2025-02-27
2023-07-02$11.00M
10-Q · filed 2024-08-05
$24.00M
10-Q · filed 2024-08-05
$32.00M
derived: sum of 3 quarters · filed 2025-02-27
$47.00M
derived: sum of 4 quarters · filed 2025-02-27
2023-04-02$13.00M
10-Q · filed 2024-05-08
$21.00M
derived: sum of 2 quarters · filed 2025-02-27
$36.00M
derived: sum of 3 quarters · filed 2025-02-27
$42.00M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$8.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$23.00M
derived: sum of 2 quarters · filed 2025-02-27
$29.00M
derived: sum of 3 quarters · filed 2025-02-27
$35.00M
10-K · filed 2025-02-27
2022-10-02$15.00M
10-Q · filed 2023-11-08
$21.00M
derived: sum of 2 quarters · filed 2023-11-08
$27.00M
10-Q · filed 2023-11-08
$25.00M
derived: sum of 4 quarters · filed 2024-02-22
2022-07-03$6.00M
10-Q · filed 2023-08-09
$12.00M
10-Q · filed 2023-08-09
$10.00M
derived: sum of 3 quarters · filed 2024-02-22
$22.00M
derived: sum of 4 quarters · filed 2024-02-22
2022-04-03$6.00M
10-Q · filed 2023-05-10
$4.00M
derived: sum of 2 quarters · filed 2024-02-22
$16.00M
derived: sum of 3 quarters · filed 2024-02-22
$42.00M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31-$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$10.00M
derived: sum of 2 quarters · filed 2024-02-22
$36.00M
derived: sum of 3 quarters · filed 2024-02-22
$45.00M
10-K · filed 2024-02-22
2021-10-03$12.00M
10-Q · filed 2022-11-09
$38.00M
derived: sum of 2 quarters · filed 2022-11-09
$47.00M
10-Q · filed 2022-11-09
$58.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-07-04$26.00M
10-Q · filed 2022-08-10
$35.00M
10-Q · filed 2022-08-10
$46.00M
derived: sum of 3 quarters · filed 2023-02-23
$54.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-04-04$9.00M
10-Q · filed 2022-05-11
$20.00M
derived: sum of 2 quarters · filed 2023-02-23
$28.00M
derived: sum of 3 quarters · filed 2023-02-23
$36.00M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$11.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$19.00M
derived: sum of 2 quarters · filed 2023-02-23
$27.00M
derived: sum of 3 quarters · filed 2023-02-23
$36.00M
10-K · filed 2023-02-23
2020-09-27$8.00M
10-Q · filed 2021-11-12
$16.00M
derived: sum of 2 quarters · filed 2021-11-12
$25.00M
10-Q · filed 2021-11-12
$35.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-28$8.00M
10-Q · filed 2021-08-12
$17.00M
10-Q · filed 2021-08-12
$27.00M
derived: sum of 3 quarters · filed 2022-02-24
$31.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-29$9.00M
10-Q · filed 2021-05-13
$19.00M
derived: sum of 2 quarters · filed 2022-02-24
$23.00M
derived: sum of 3 quarters · filed 2022-02-24
$33.00M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$10.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$14.00M
derived: sum of 2 quarters · filed 2022-02-24
$24.00M
derived: sum of 3 quarters · filed 2022-02-24
$29.00M
10-K · filed 2022-02-24
2019-09-29$4.00M
10-Q · filed 2020-11-05
$14.00M
derived: sum of 2 quarters · filed 2020-11-05
$19.00M
10-Q · filed 2020-11-05
$31.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$10.00M
10-Q · filed 2020-08-06
$15.00M
10-Q · filed 2020-08-06
$27.00M
derived: sum of 3 quarters · filed 2021-02-25
$35.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$6.00M
10-Q · filed 2020-05-07
$17.00M
derived: sum of 2 quarters · filed 2021-02-25
$25.00M
derived: sum of 3 quarters · filed 2021-02-25
$32.00M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$11.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$19.00M
derived: sum of 2 quarters · filed 2021-02-25
$26.00M
derived: sum of 3 quarters · filed 2021-02-25
$36.00M
10-K · filed 2021-02-25
2018-09-30$8.00M
10-Q · filed 2019-11-07
$15.00M
derived: sum of 2 quarters · filed 2019-11-07
$25.00M
10-Q · filed 2019-11-07
$39.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-07-01$7.00M
10-Q · filed 2019-08-08
$16.00M
10-Q · filed 2019-08-08
$31.00M
derived: sum of 3 quarters · filed 2020-02-27
$49.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-04-01$9.00M
10-Q · filed 2019-05-09
$24.00M
derived: sum of 2 quarters · filed 2020-02-27
$42.00M
derived: sum of 3 quarters · filed 2020-02-27
$47.00M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$15.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$33.00M
derived: sum of 2 quarters · filed 2020-02-27
$38.00M
derived: sum of 3 quarters · filed 2020-02-27
$47.00M
10-K · filed 2020-02-27
2017-10-01$18.00M
10-Q · filed 2018-11-08
$23.00M
derived: sum of 2 quarters · filed 2018-11-08
$32.00M
10-Q · filed 2018-11-08
$38.00M
derived: sum of 4 quarters · filed 2019-02-28
2017-07-02$5.00M
10-Q · filed 2018-08-09
$14.00M
10-Q · filed 2018-08-09
$20.00M
derived: sum of 3 quarters · filed 2019-02-28
$20.00M
derived: sum of 4 quarters · filed 2019-02-28
2017-04-02$9.00M
10-Q · filed 2018-05-10
$15.00M
derived: sum of 2 quarters · filed 2019-02-28
$15.00M
derived: sum of 3 quarters · filed 2019-02-28
$31.00M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$6.00M
derived: sum of 2 quarters · filed 2019-02-28
$22.00M
derived: sum of 3 quarters · filed 2019-02-28
$31.00M
10-K · filed 2019-02-28
2016-10-02$0.00
10-Q · filed 2017-11-09
$16.00M
derived: sum of 2 quarters · filed 2017-11-09
$25.00M
10-Q · filed 2017-11-09
$28.00M
derived: sum of 4 quarters · filed 2018-02-22
2016-07-03$16.00M
10-Q · filed 2017-08-10
$25.00M
10-Q · filed 2017-08-10
$28.00M
derived: sum of 3 quarters · filed 2018-02-22
$37.00M
derived: sum of 4 quarters · filed 2018-02-22
2016-04-03$9.00M
10-Q · filed 2017-05-11
$12.00M
derived: sum of 2 quarters · filed 2018-02-22
$21.00M
derived: sum of 3 quarters · filed 2018-02-22
$30.00M
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
$12.00M
derived: sum of 2 quarters · filed 2018-02-22
$21.00M
derived: sum of 3 quarters · filed 2018-02-22
$26.00M
10-K · filed 2018-02-22
2015-09-27$9.00M
10-Q · filed 2016-11-10
$18.00M
derived: sum of 2 quarters · filed 2016-11-10
$23.00M
10-Q · filed 2016-11-10
$31.00M
derived: sum of 4 quarters · filed 2017-02-23
2015-06-28$9.00M
10-Q · filed 2016-08-11
$14.00M
10-Q · filed 2016-08-11
$22.00M
derived: sum of 3 quarters · filed 2017-02-23
$28.00M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-29$6.00M
10-Q · filed 2016-05-12
$13.00M
derived: sum of 2 quarters · filed 2017-02-23
$19.00M
derived: sum of 3 quarters · filed 2017-02-23
$28.00M
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31$7.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
$13.00M
derived: sum of 2 quarters · filed 2017-02-23
$22.00M
derived: sum of 3 quarters · filed 2017-02-23
$32.00M
10-K · filed 2017-02-23
2014-09-28$6.00M
10-Q · filed 2015-11-05
$15.00M
derived: sum of 2 quarters · filed 2015-11-05
$25.00M
10-Q · filed 2015-11-05
$30.00M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-29$9.00M
10-Q · filed 2015-08-06
$18.00M
10-Q · filed 2015-08-06
$24.00M
derived: sum of 3 quarters · filed 2016-02-29
$33.00M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-30$9.00M
10-Q · filed 2015-05-07
$15.00M
derived: sum of 2 quarters · filed 2016-02-29
$24.00M
derived: sum of 3 quarters · filed 2016-02-29
$63.00M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$15.00M
derived: sum of 2 quarters · filed 2016-02-29
$54.00M
derived: sum of 3 quarters · filed 2016-02-29
$69.00M
10-K · filed 2016-02-29
2013-09-29$9.00M
10-Q · filed 2014-11-06
$48.00M
derived: sum of 2 quarters · filed 2014-11-06
$63.00M
10-Q · filed 2014-11-06
$69.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30$39.00M
10-Q · filed 2014-08-07
$54.00M
10-Q · filed 2014-08-07
$60.00M
derived: sum of 3 quarters · filed 2015-02-27
$66.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$15.00M
10-Q · filed 2014-05-08
$21.00M
derived: sum of 2 quarters · filed 2015-02-27
$27.00M
derived: sum of 3 quarters · filed 2015-02-27
$34.00M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$12.00M
derived: sum of 2 quarters · filed 2015-02-27
$19.00M
derived: sum of 3 quarters · filed 2015-02-27
$28.00M
10-K · filed 2015-02-27
2012-09-30$6.00M
10-Q · filed 2013-11-08
$13.00M
derived: sum of 2 quarters · filed 2013-11-08
$22.00M
10-Q · filed 2013-11-08
$31.00M
derived: sum of 4 quarters · filed 2014-02-28
2012-07-01$7.00M
10-Q · filed 2013-08-09
$16.00M
10-Q · filed 2013-08-09
$25.00M
derived: sum of 3 quarters · filed 2014-02-28
$36.00M
derived: sum of 4 quarters · filed 2014-02-28
2012-04-01$9.00M
10-Q · filed 2013-05-10
$18.00M
derived: sum of 2 quarters · filed 2014-02-28
$29.00M
derived: sum of 3 quarters · filed 2014-02-28
$37.00M
derived: sum of 4 quarters · filed 2014-02-28
2011-12-31$9.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28
$20.00M
derived: sum of 2 quarters · filed 2014-02-28
$28.00M
derived: sum of 3 quarters · filed 2014-02-28
$40.00M
10-K · filed 2014-02-28
$42.00M
10-K · filed 2012-02-28
2011-10-02$11.00M
10-Q · filed 2012-11-09
$19.00M
derived: sum of 2 quarters · filed 2012-11-09
$31.00M
10-Q · filed 2012-11-09
$38.00M
derived: sum of 4 quarters · filed 2013-02-28
2011-07-03$8.00M
10-Q · filed 2011-08-11
$20.00M
10-Q · filed 2012-08-09
$27.00M
derived: sum of 3 quarters · filed 2013-02-28
$32.00M
derived: sum of 4 quarters · filed 2013-02-28
2011-04-03$12.00M
10-Q · filed 2012-05-10
$19.00M
derived: sum of 2 quarters · filed 2013-02-28
$24.00M
derived: sum of 3 quarters · filed 2013-02-28
$34.00M
derived: sum of 4 quarters · filed 2013-02-28
2010-12-31$7.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$12.00M
derived: sum of 2 quarters · filed 2013-02-28
$22.00M
derived: sum of 3 quarters · filed 2013-02-28
$31.00M
10-K · filed 2013-02-28
$32.00M
10-K · filed 2011-02-28
2010-10-03$5.00M
10-Q · filed 2011-11-10
$15.00M
derived: sum of 2 quarters · filed 2011-11-10
$24.00M
10-Q · filed 2011-11-10
$23.00M
derived: sum of 4 quarters · filed 2012-02-28
2010-07-04$10.00M
10-Q · filed 2011-08-11
$19.00M
10-Q · filed 2011-08-11
$18.00M
derived: sum of 3 quarters · filed 2012-02-28
$21.00M
derived: sum of 4 quarters · filed 2012-02-28
2010-04-04$9.00M
10-Q · filed 2011-05-12
$8.00M
derived: sum of 2 quarters · filed 2012-02-28
$11.00M
derived: sum of 3 quarters · filed 2012-02-28
$16.00M
derived: sum of 4 quarters · filed 2012-02-28
2009-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
$2.00M
derived: sum of 2 quarters · filed 2012-02-28
$7.00M
derived: sum of 3 quarters · filed 2012-02-28
$8.00M
10-K · filed 2012-02-28
$9.00M
10-K · filed 2010-02-26
2009-09-27$3.00M
10-Q · filed 2010-11-12
$8.00M
derived: sum of 2 quarters · filed 2010-11-12
$9.00M
10-Q · filed 2010-11-12
$14.00M
derived: sum of 4 quarters · filed 2011-02-28
2009-06-28$5.00M
10-Q · filed 2010-08-12
$6.00M
10-Q · filed 2010-08-12
$11.00M
derived: sum of 3 quarters · filed 2011-02-28
$17.00M
derived: sum of 4 quarters · filed 2011-02-28
2009-03-29$1.00M
10-Q · filed 2010-05-13
$6.00M
derived: sum of 2 quarters · filed 2011-02-28
$12.00M
derived: sum of 3 quarters · filed 2011-02-28
$18.00M
derived: sum of 4 quarters · filed 2011-02-28
2008-12-31$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28
$11.00M
derived: sum of 2 quarters · filed 2011-02-28
$17.00M
derived: sum of 3 quarters · filed 2011-02-28
$23.00M
10-K · filed 2011-02-28
2008-09-28$6.00M
10-Q · filed 2009-11-05
$12.00M
derived: sum of 2 quarters · filed 2009-11-05
$18.00M
10-Q · filed 2009-11-05
2008-06-29$6.00M
10-Q · filed 2009-08-06
$12.00M
10-Q · filed 2009-08-06
2007-12-31$42.00M
10-K · filed 2010-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64